BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 23891399)

  • 21. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.
    LaRusch J; Jung J; General IJ; Lewis MD; Park HW; Brand RE; Gelrud A; Anderson MA; Banks PA; Conwell D; Lawrence C; Romagnuolo J; Baillie J; Alkaade S; Cote G; Gardner TB; Amann ST; Slivka A; Sandhu B; Aloe A; Kienholz ML; Yadav D; Barmada MM; Bahar I; Lee MG; Whitcomb DC;
    PLoS Genet; 2014 Jul; 10(7):e1004376. PubMed ID: 25033378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NGS-Based Assay for the Identification of Individuals Carrying Recessive Genetic Mutations in Reproductive Medicine.
    Abulí A; Boada M; Rodríguez-Santiago B; Coroleu B; Veiga A; Armengol L; Barri PN; Pérez-Jurado LA; Estivill X
    Hum Mutat; 2016 Jun; 37(6):516-23. PubMed ID: 26990548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis.
    De Boeck K; Zolin A; Cuppens H; Olesen HV; Viviani L
    J Cyst Fibros; 2014 Jul; 13(4):403-9. PubMed ID: 24440181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients.
    Miyagawa M; Naito T; Nishio SY; Kamatani N; Usami S
    PLoS One; 2013; 8(8):e71381. PubMed ID: 23967202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity.
    Bachmann-Gagescu R; Dempsey JC; Phelps IG; O'Roak BJ; Knutzen DM; Rue TC; Ishak GE; Isabella CR; Gorden N; Adkins J; Boyle EA; de Lacy N; O'Day D; Alswaid A; Ramadevi A R; Lingappa L; Lourenço C; Martorell L; Garcia-Cazorla À; Ozyürek H; Haliloğlu G; Tuysuz B; Topçu M; ; Chance P; Parisi MA; Glass IA; Shendure J; Doherty D
    J Med Genet; 2015 Aug; 52(8):514-22. PubMed ID: 26092869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs.
    Schulz HL; Grassmann F; Kellner U; Spital G; Rüther K; Jägle H; Hufendiek K; Rating P; Huchzermeyer C; Baier MJ; Weber BH; Stöhr H
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):394-403. PubMed ID: 28118664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss.
    Sloan-Heggen CM; Bierer AO; Shearer AE; Kolbe DL; Nishimura CJ; Frees KL; Ephraim SS; Shibata SB; Booth KT; Campbell CA; Ranum PT; Weaver AE; Black-Ziegelbein EA; Wang D; Azaiez H; Smith RJH
    Hum Genet; 2016 Apr; 135(4):441-450. PubMed ID: 26969326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
    Walsh R; Thomson KL; Ware JS; Funke BH; Woodley J; McGuire KJ; Mazzarotto F; Blair E; Seller A; Taylor JC; Minikel EV; Exome Aggregation Consortium ; MacArthur DG; Farrall M; Cook SA; Watkins H
    Genet Med; 2017 Feb; 19(2):192-203. PubMed ID: 27532257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients.
    Bonnet C; Riahi Z; Chantot-Bastaraud S; Smagghe L; Letexier M; Marcaillou C; Lefèvre GM; Hardelin JP; El-Amraoui A; Singh-Estivalet A; Mohand-Saïd S; Kohl S; Kurtenbach A; Sliesoraityte I; Zobor D; Gherbi S; Testa F; Simonelli F; Banfi S; Fakin A; Glavač D; Jarc-Vidmar M; Zupan A; Battelino S; Martorell Sampol L; Claveria MA; Catala Mora J; Dad S; Møller LB; Rodriguez Jorge J; Hawlina M; Auricchio A; Sahel JA; Marlin S; Zrenner E; Audo I; Petit C
    Eur J Hum Genet; 2016 Dec; 24(12):1730-1738. PubMed ID: 27460420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    J Cyst Fibros; 2015 Nov; 14(6):714-9. PubMed ID: 25824995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
    Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
    Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of protein-coding genetic variation in 60,706 humans.
    Lek M; Karczewski KJ; Minikel EV; Samocha KE; Banks E; Fennell T; O'Donnell-Luria AH; Ware JS; Hill AJ; Cummings BB; Tukiainen T; Birnbaum DP; Kosmicki JA; Duncan LE; Estrada K; Zhao F; Zou J; Pierce-Hoffman E; Berghout J; Cooper DN; Deflaux N; DePristo M; Do R; Flannick J; Fromer M; Gauthier L; Goldstein J; Gupta N; Howrigan D; Kiezun A; Kurki MI; Moonshine AL; Natarajan P; Orozco L; Peloso GM; Poplin R; Rivas MA; Ruano-Rubio V; Rose SA; Ruderfer DM; Shakir K; Stenson PD; Stevens C; Thomas BP; Tiao G; Tusie-Luna MT; Weisburd B; Won HH; Yu D; Altshuler DM; Ardissino D; Boehnke M; Danesh J; Donnelly S; Elosua R; Florez JC; Gabriel SB; Getz G; Glatt SJ; Hultman CM; Kathiresan S; Laakso M; McCarroll S; McCarthy MI; McGovern D; McPherson R; Neale BM; Palotie A; Purcell SM; Saleheen D; Scharf JM; Sklar P; Sullivan PF; Tuomilehto J; Tsuang MT; Watkins HC; Wilson JG; Daly MJ; MacArthur DG;
    Nature; 2016 Aug; 536(7616):285-91. PubMed ID: 27535533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing.
    Huang XF; Huang F; Wu KC; Wu J; Chen J; Pang CP; Lu F; Qu J; Jin ZB
    Genet Med; 2015 Apr; 17(4):271-8. PubMed ID: 25356976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene.
    Mercier B; Lissens W; Novelli G; Kalaydjieva L; De Arce M; Kapranov N; Klain NC; Lenoir G; Chauveau P; Lenaerts C
    Genomics; 1993 Apr; 16(1):296-7. PubMed ID: 7683628
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical application of whole-exome sequencing across clinical indications.
    Retterer K; Juusola J; Cho MT; Vitazka P; Millan F; Gibellini F; Vertino-Bell A; Smaoui N; Neidich J; Monaghan KG; McKnight D; Bai R; Suchy S; Friedman B; Tahiliani J; Pineda-Alvarez D; Richard G; Brandt T; Haverfield E; Chung WK; Bale S
    Genet Med; 2016 Jul; 18(7):696-704. PubMed ID: 26633542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.
    Karaca E; Harel T; Pehlivan D; Jhangiani SN; Gambin T; Coban Akdemir Z; Gonzaga-Jauregui C; Erdin S; Bayram Y; Campbell IM; Hunter JV; Atik MM; Van Esch H; Yuan B; Wiszniewski W; Isikay S; Yesil G; Yuregir OO; Tug Bozdogan S; Aslan H; Aydin H; Tos T; Aksoy A; De Vivo DC; Jain P; Geckinli BB; Sezer O; Gul D; Durmaz B; Cogulu O; Ozkinay F; Topcu V; Candan S; Cebi AH; Ikbal M; Yilmaz Gulec E; Gezdirici A; Koparir E; Ekici F; Coskun S; Cicek S; Karaer K; Koparir A; Duz MB; Kirat E; Fenercioglu E; Ulucan H; Seven M; Guran T; Elcioglu N; Yildirim MS; Aktas D; Alikaşifoğlu M; Ture M; Yakut T; Overton JD; Yuksel A; Ozen M; Muzny DM; Adams DR; Boerwinkle E; Chung WK; Gibbs RA; Lupski JR
    Neuron; 2015 Nov; 88(3):499-513. PubMed ID: 26539891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
    Susswein LR; Marshall ML; Nusbaum R; Vogel Postula KJ; Weissman SM; Yackowski L; Vaccari EM; Bissonnette J; Booker JK; Cremona ML; Gibellini F; Murphy PD; Pineda-Alvarez DE; Pollevick GD; Xu Z; Richard G; Bale S; Klein RT; Hruska KS; Chung WK
    Genet Med; 2016 Aug; 18(8):823-32. PubMed ID: 26681312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies.
    Eisenberger T; Neuhaus C; Khan AO; Decker C; Preising MN; Friedburg C; Bieg A; Gliem M; Charbel Issa P; Holz FG; Baig SM; Hellenbroich Y; Galvez A; Platzer K; Wollnik B; Laddach N; Ghaffari SR; Rafati M; Botzenhart E; Tinschert S; Börger D; Bohring A; Schreml J; Körtge-Jung S; Schell-Apacik C; Bakur K; Al-Aama JY; Neuhann T; Herkenrath P; Nürnberg G; Nürnberg P; Davis JS; Gal A; Bergmann C; Lorenz B; Bolz HJ
    PLoS One; 2013; 8(11):e78496. PubMed ID: 24265693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.